Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.
Patrick Yang Ph.D.
Dr. Patrick Y. Yang was appointed to the Board of Amyris, effective July 1, 2014. From January 2010 to March 2013, he served as Head of Global Technical Operations for F. Hoffmann-La Roche Ltd. where he was responsible for the company's pharmaceutical manufacturing, process development, engineering, quality, regulatory, supply chain and procurement. Before joining Roche, he worked for Genentech, Merck & Co., General Electric and Life Systems, during which time he developed significant experience with pharmaceuticals and biotechnology manufacturing, engineering, technology, and supply chain management. Dr. Yang currently serves on the board of directors of Tesoro Corporation, a public independent petroleum refining and marketing company, since December 2010; Codexis, a public company that develops biocatalysts for the pharmaceutical and fine chemicals markets, since February 2014; and PharmaEssentia Corporation, a clinical-stage biotechnology company, since March 2014; and previously served on the board of TaiMed, Inc. in 2007-2009; and Celladon Corporation in 2014-2015: both are clinical-stage biotechnology companies. Dr. Yang earned a Bachelor of Science in Engineering from the National Chiaotung University in Taiwan, a Master of Science in Electrical Engineering from the University of Cincinnati and a Ph.D. in engineering from the Ohio State University.
Member of the Leadership, Development, Inclusion and Compensation Committee.